Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

BUD

Will Market Sentiment Support BUD's Price Surge?

This afternoon we watched Anheuser-Busch Inbev rise 1.5% to a price of $71.77 per share. The Large-Cap Beverages company is now trading -6.75% below its average target price of $76.96. Analysts have set target prices ranging from $65.0 to $88.0 per share for Anheuser-Busch Inbev, and have given the stock an average rating of buy.

The stock has a very low short interest at 0.7%, and a short ratio of 2.96. At 0.0%, the company's rate of insider ownership does not indicate that management is heavily invested in the corporation. Finally, we also note that a very small number of institutional investors are invested in the stock, with 6.2% of Anheuser-Busch Inbev's shares being owned by this investor type.

Institutions Invested in Anheuser-Busch Inbev

Date Reported Holder Percentage Shares Value
2025-03-31 Dodge & Cox Inc 2% 41,116,138 $2,950,699,618
2025-03-31 Fisher Asset Management, LLC 1% 10,209,312 $732,671,269
2025-03-31 Manufacturers Life Insurance Co. 0% 7,223,862 $518,420,452
2025-03-31 Royal Bank of Canada 0% 3,952,079 $283,620,947
2025-03-31 Hotchkis & Wiley Capital Management, LLC 0% 2,790,240 $200,241,571
2025-03-31 Morgan Stanley 0% 2,843,532 $204,066,072
2025-03-31 Bank of America Corporation 0% 2,703,293 $194,001,820
2025-03-31 Capital International Investors 0% 2,356,983 $169,148,883
2025-03-31 Davenport & Co LLC 0% 2,161,793 $155,141,073
2025-03-31 Arrowstreet Capital, Limited Partnership 0% 1,818,772 $130,524,171

Besides an analyst consensus of some upside potential, other market factors point to there being mixed market sentiment on Anheuser-Busch Inbev.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS